Rhythm

Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke

Study Published in JAMA Cardiology Demonstrates a Three-Fold Increased Risk of Ischemic Stroke Within 30 Days of a Multi-Hour AF Event DUBLIN, Oct. 4, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the publication of a study demonstrating, through the use of a Medtronic continuous rhythm monitoring […]

Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON)

Completion of patient enrolment expected before end of year Primary endpoint read-out due in Q4 2022 59 patients already recruited in the Pivotal Cohort Ghent, Belgium – 4 October 2021 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver […]

Match Health Academy Launches Innovative Video-Based Courses on Atrial Fibrillation (AFib)

SANTA CLARA, Calif., Sept. 30, 2021 /PRNewswire/ — Match Health Academy has launched three online, expert-guided, video-based courses designed to help patients and their families better understand and manage AFib. The three courses offered include: AFib Essentials, The Ultimate Guide to Afib Nutrition and The Ultimate Guide to Yoga for AFib. The courses are designed to […]

Dr. Willcox Presents Study at Heart Rhythm Society: When Reviewing Heart Monitor Data, Human Technicians Outperform Artificial Intelligence by Over 200 Percent

ANCHORAGE, Alaska, Sept. 28, 2021 /PRNewswire/ — A pilot study led by Alaska Heart & Vascular Institute’s (AHVI) electrophysiologist Mark E. Willcox, MD, found that human-led diagnostic data interpretation outperformed artificiual intelligence (AI) screenings by over 200 percent. As a study initially designed to compare the performance of two common cardiac monitors—the BioGuardian by […]

FDA Clears Caretaker Medical’s Wireless Platform for Continuous Noninvasive Blood Pressure and Hemodynamic Monitoring

Innovative Next-Generation Technology Monitors the Most Important Vital Signs for Cardiovascular Health CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, today announced U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform. Continuous […]

Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation

First and only manufacturer-prepared premix formulation of norepinephrine available Offers variety of storage options under refrigeration and at room temperature, allowing drug to be placed closer to patient care settings Ready-to-use format means less chance of compounding errors and touch contamination associated with compounded drug formulations DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International […]

Cardiac Insight Announces Partnership with Lovell Government Services to Extend Distribution Capabilities to U.S. Department of Defense and Veterans Affairs Medical Facilities

Partnership Expands Access to Cardea SOLO™ Digital Health Solution for Early Atrial Fibrillation Detection and Diagnosis to Veterans and Active-Duty Military Personnel BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc.(“Cardiac Insight” or the “Company”) is a US-based healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) testing […]

Huadong Medicine and PulseCath Announce Strategic Collaboration to Develop and Commercialize the iVAC mechanical circulatory product in Greater China

Partnership accelerates the development of the iVAC 2L mechanical circulatory device in Greater China. Expands Huadong Medicine’s medical portfolio for cases of high-risk PCI with innovative percutaneous ventricle assist devices based on innovative pulsatile technology. PulseCath will receive a significant investment in its share capital and in payments for regulatory […]

Cardialen Awarded $3 Million Federal Grant to Advance Therapy Designed to Treat Atrial Fibrillation for Improved Heart Failure Outcomes

National Institutes of Health grant will support Cardialen’s development of its implantable, low-energy therapy designed to treat atrial fibrillation, a cardiac arrhythmia associated with debilitating shortness of breath, fatigue, pain, and an increased risk of stroke. MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., has been awarded a $3 million National Institutes of Health (NIH) […]